Biologics for the prevention of mycoplasma pneumonia in pigs
This report contains market size and forecasts of Swine Mycoplasma Hyopneumoniae Vaccine in global, including the following market information:
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Sales, 2018-2023, 2023-2030, (Box)
Global top five Swine Mycoplasma Hyopneumoniae Vaccine companies in 2022 (%)
The global Swine Mycoplasma Hyopneumoniae Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Swine Pseudorabies Vaccine, Live Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Swine Mycoplasma Hyopneumoniae Vaccine include Yongshun Creatures, Pfizer, Boehringer Ingelheim, Bayer, Elanco, MSD, Cahic, Ringpu and Baoling, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Swine Mycoplasma Hyopneumoniae Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Swine Mycoplasma Hyopneumoniae Vaccine Market, by Activity, 2018-2023, 2023-2030 ($ Millions) & (Box)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Segment Percentages, by Activity, 2022 (%)
Swine Pseudorabies Vaccine, Live
Swine Pseudorabies Vaccine, Inactivated
Global Swine Mycoplasma Hyopneumoniae Vaccine Market, by Downstream, 2018-2023, 2023-2030 ($ Millions) & (Box)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Segment Percentages, by Downstream, 2022 (%)
Farms
Individual
Global Swine Mycoplasma Hyopneumoniae Vaccine Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Box)
Global Swine Mycoplasma Hyopneumoniae Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Swine Mycoplasma Hyopneumoniae Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Swine Mycoplasma Hyopneumoniae Vaccine revenues share in global market, 2022 (%)
Key companies Swine Mycoplasma Hyopneumoniae Vaccine sales in global market, 2018-2023 (Estimated), (Box)
Key companies Swine Mycoplasma Hyopneumoniae Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Yongshun Creatures
Pfizer
Boehringer Ingelheim
Bayer
Elanco
MSD
Cahic
Ringpu
Baoling
Jizhong
Dahuanong
Keqian Biology
Hayao
Pulike Biology
Tecon
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Swine Mycoplasma Hyopneumoniae Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Activity
1.2.2 Market by Downstream
1.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Swine Mycoplasma Hyopneumoniae Vaccine Overall Market Size
2.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size: 2022 VS 2030
2.2 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Swine Mycoplasma Hyopneumoniae Vaccine Players in Global Market
3.2 Top Global Swine Mycoplasma Hyopneumoniae Vaccine Companies Ranked by Revenue
3.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Companies
3.4 Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Companies
3.5 Global Swine Mycoplasma Hyopneumoniae Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Swine Mycoplasma Hyopneumoniae Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Swine Mycoplasma Hyopneumoniae Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Swine Mycoplasma Hyopneumoniae Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Swine Mycoplasma Hyopneumoniae Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Swine Mycoplasma Hyopneumoniae Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size Markets, 2022 & 2030
4.1.2 Swine Pseudorabies Vaccine, Live
4.1.3 Swine Pseudorabies Vaccine, Inactivated
4.2 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue & Forecasts
4.2.1 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2023
4.2.2 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2023-2030
4.2.3 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
4.3 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales & Forecasts
4.3.1 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2023
4.3.2 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2023-2030
4.3.3 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
4.4 By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Downstream
5.1 Overview
5.1.1 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2022 & 2030
5.1.2 Farms
5.1.3 Individual
5.2 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue & Forecasts
5.2.1 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2023
5.2.2 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2023-2030
5.2.3 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
5.3 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales & Forecasts
5.3.1 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2023
5.3.2 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2023-2030
5.3.3 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
5.4 By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue & Forecasts
6.2.1 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2023-2030
6.2.3 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales & Forecasts
6.3.1 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2023
6.3.2 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2023-2030
6.3.3 By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2030
6.4.3 US Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.4.4 Canada Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.4.5 Mexico Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2030
6.5.3 Germany Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.5.4 France Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.5.5 U.K. Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.5.6 Italy Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.5.7 Russia Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.5.9 Benelux Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2030
6.6.3 China Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.6.4 Japan Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.6.5 South Korea Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.6.7 India Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2030
6.7.3 Brazil Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.7.4 Argentina Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales, 2018-2030
6.8.3 Turkey Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.8.4 Israel Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
6.8.6 UAE Swine Mycoplasma Hyopneumoniae Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Yongshun Creatures
7.1.1 Yongshun Creatures Corporate Summary
7.1.2 Yongshun Creatures Business Overview
7.1.3 Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.1.4 Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Yongshun Creatures Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.2.4 Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.3.4 Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.4.4 Bayer Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Bayer Key News
7.5 Elanco
7.5.1 Elanco Corporate Summary
7.5.2 Elanco Business Overview
7.5.3 Elanco Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.5.4 Elanco Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Elanco Key News
7.6 MSD
7.6.1 MSD Corporate Summary
7.6.2 MSD Business Overview
7.6.3 MSD Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.6.4 MSD Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 MSD Key News
7.7 Cahic
7.7.1 Cahic Corporate Summary
7.7.2 Cahic Business Overview
7.7.3 Cahic Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.7.4 Cahic Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Cahic Key News
7.8 Ringpu
7.8.1 Ringpu Corporate Summary
7.8.2 Ringpu Business Overview
7.8.3 Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.8.4 Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Ringpu Key News
7.9 Baoling
7.9.1 Baoling Corporate Summary
7.9.2 Baoling Business Overview
7.9.3 Baoling Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.9.4 Baoling Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Baoling Key News
7.10 Jizhong
7.10.1 Jizhong Corporate Summary
7.10.2 Jizhong Business Overview
7.10.3 Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.10.4 Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Jizhong Key News
7.11 Dahuanong
7.11.1 Dahuanong Corporate Summary
7.11.2 Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Business Overview
7.11.3 Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.11.4 Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Dahuanong Key News
7.12 Keqian Biology
7.12.1 Keqian Biology Corporate Summary
7.12.2 Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Business Overview
7.12.3 Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.12.4 Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Keqian Biology Key News
7.13 Hayao
7.13.1 Hayao Corporate Summary
7.13.2 Hayao Swine Mycoplasma Hyopneumoniae Vaccine Business Overview
7.13.3 Hayao Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.13.4 Hayao Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Hayao Key News
7.14 Pulike Biology
7.14.1 Pulike Biology Corporate Summary
7.14.2 Pulike Biology Business Overview
7.14.3 Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.14.4 Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Pulike Biology Key News
7.15 Tecon
7.15.1 Tecon Corporate Summary
7.15.2 Tecon Business Overview
7.15.3 Tecon Swine Mycoplasma Hyopneumoniae Vaccine Major Product Offerings
7.15.4 Tecon Swine Mycoplasma Hyopneumoniae Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Tecon Key News
8 Global Swine Mycoplasma Hyopneumoniae Vaccine Production Capacity, Analysis
8.1 Global Swine Mycoplasma Hyopneumoniae Vaccine Production Capacity, 2018-2030
8.2 Swine Mycoplasma Hyopneumoniae Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Swine Mycoplasma Hyopneumoniae Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Swine Mycoplasma Hyopneumoniae Vaccine Supply Chain Analysis
10.1 Swine Mycoplasma Hyopneumoniae Vaccine Industry Value Chain
10.2 Swine Mycoplasma Hyopneumoniae Vaccine Upstream Market
10.3 Swine Mycoplasma Hyopneumoniae Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Swine Mycoplasma Hyopneumoniae Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Swine Mycoplasma Hyopneumoniae Vaccine in Global Market
Table 2. Top Swine Mycoplasma Hyopneumoniae Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales by Companies, (Box), 2018-2023
Table 6. Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Swine Mycoplasma Hyopneumoniae Vaccine Price (2018-2023) & (US$/Box)
Table 8. Global Manufacturers Swine Mycoplasma Hyopneumoniae Vaccine Product Type
Table 9. List of Global Tier 1 Swine Mycoplasma Hyopneumoniae Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Swine Mycoplasma Hyopneumoniae Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Activity ? Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue (US$, Mn), 2023-2030
Table 14. By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), 2018-2023
Table 15. By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), 2023-2030
Table 16. By Downstream ? Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue (US$, Mn), 2023-2030
Table 19. By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), 2018-2023
Table 20. By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), 2023-2030
Table 21. By Region ? Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), 2018-2023
Table 25. By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), 2023-2030
Table 26. By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2018-2023
Table 29. By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2023-2030
Table 30. By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2018-2023
Table 33. By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2023-2030
Table 34. By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2018-2023
Table 37. By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2023-2030
Table 38. By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2018-2023
Table 41. By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2023-2030
Table 42. By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2018-2023
Table 45. By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales, (Box), 2023-2030
Table 46. Yongshun Creatures Corporate Summary
Table 47. Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 48. Yongshun Creatures Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 51. Pfizer Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 52. Boehringer Ingelheim Corporate Summary
Table 53. Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 54. Boehringer Ingelheim Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 55. Bayer Corporate Summary
Table 56. Bayer Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 57. Bayer Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 58. Elanco Corporate Summary
Table 59. Elanco Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 60. Elanco Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 61. MSD Corporate Summary
Table 62. MSD Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 63. MSD Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 64. Cahic Corporate Summary
Table 65. Cahic Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 66. Cahic Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 67. Ringpu Corporate Summary
Table 68. Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 69. Ringpu Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 70. Baoling Corporate Summary
Table 71. Baoling Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 72. Baoling Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 73. Jizhong Corporate Summary
Table 74. Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 75. Jizhong Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 76. Dahuanong Corporate Summary
Table 77. Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 78. Dahuanong Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 79. Keqian Biology Corporate Summary
Table 80. Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 81. Keqian Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 82. Hayao Corporate Summary
Table 83. Hayao Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 84. Hayao Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 85. Pulike Biology Corporate Summary
Table 86. Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 87. Pulike Biology Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 88. Tecon Corporate Summary
Table 89. Tecon Swine Mycoplasma Hyopneumoniae Vaccine Product Offerings
Table 90. Tecon Swine Mycoplasma Hyopneumoniae Vaccine Sales (Box), Revenue (US$, Mn) and Average Price (US$/Box) (2018-2023)
Table 91. Swine Mycoplasma Hyopneumoniae Vaccine Production Capacity (Box) of Key Manufacturers in Global Market, 2020-2023 (Box)
Table 92. Global Swine Mycoplasma Hyopneumoniae Vaccine Capacity Market Share of Key Manufacturers, 2020-2023
Table 93. Global Swine Mycoplasma Hyopneumoniae Vaccine Production by Region, 2018-2023 (Box)
Table 94. Global Swine Mycoplasma Hyopneumoniae Vaccine Production by Region, 2023-2030 (Box)
Table 95. Swine Mycoplasma Hyopneumoniae Vaccine Market Opportunities & Trends in Global Market
Table 96. Swine Mycoplasma Hyopneumoniae Vaccine Market Drivers in Global Market
Table 97. Swine Mycoplasma Hyopneumoniae Vaccine Market Restraints in Global Market
Table 98. Swine Mycoplasma Hyopneumoniae Vaccine Raw Materials
Table 99. Swine Mycoplasma Hyopneumoniae Vaccine Raw Materials Suppliers in Global Market
Table 100. Typical Swine Mycoplasma Hyopneumoniae Vaccine Downstream
Table 101. Swine Mycoplasma Hyopneumoniae Vaccine Downstream Clients in Global Market
Table 102. Swine Mycoplasma Hyopneumoniae Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Swine Mycoplasma Hyopneumoniae Vaccine Segment by Activity
Figure 2. Swine Mycoplasma Hyopneumoniae Vaccine Segment by Downstream
Figure 3. Global Swine Mycoplasma Hyopneumoniae Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Swine Mycoplasma Hyopneumoniae Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Swine Mycoplasma Hyopneumoniae Vaccine Sales in Global Market: 2018-2030 (Box)
Figure 8. The Top 3 and 5 Players Market Share by Swine Mycoplasma Hyopneumoniae Vaccine Revenue in 2022
Figure 9. By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 10. By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 11. By Activity - Global Swine Mycoplasma Hyopneumoniae Vaccine Price (US$/Box), 2018-2030
Figure 12. By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 13. By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 14. By Downstream - Global Swine Mycoplasma Hyopneumoniae Vaccine Price (US$/Box), 2018-2030
Figure 15. By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 16. By Region - Global Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 17. By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 18. By Country - North America Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 19. US Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 24. Germany Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. France Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 33. China Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 37. India Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 39. By Country - South America Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 40. Brazil Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Swine Mycoplasma Hyopneumoniae Vaccine Sales Market Share, 2018-2030
Figure 44. Turkey Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Swine Mycoplasma Hyopneumoniae Vaccine Revenue, (US$, Mn), 2018-2030
Figure 48. Global Swine Mycoplasma Hyopneumoniae Vaccine Production Capacity (Box), 2018-2030
Figure 49. The Percentage of Production Swine Mycoplasma Hyopneumoniae Vaccine by Region, 2022 VS 2030
Figure 50. Swine Mycoplasma Hyopneumoniae Vaccine Industry Value Chain
Figure 51. Marketing Channels
